Market & Industry Briefs
Executive Summary
Brief summaries of recent medtech market and industry developments. This month we cover trial results for PFO closure devices, the launch of Edwards Lifesciences' transcatheter valve, Accumetrics' push for platelet testing, J&J's acquisition of Micrus, the slowdown in the hip and knee market, and the new federal rule on covering preventive screening
You may also be interested in...
Market & Industry Briefs, November 2012
Brief summaries of recent medtech market and industry developments. This month we cover China’s switch to a centralized billing system, St. Jude Medical’s RESPECT PFO closure trial, FDA’s approval of HeartWare’s LVAD, and end-of-the-year medtech M&A.
Market & Industry Briefs
Brief summaries of recent medtech market and industry developments. This month we cover Covidien's acquisition of ev3, J&J's moves in the endovascular market, DePuy's launch of new products in hip revision, and FDA regulation of consumer genomics.
New Avenues in Neuromodulation
Implantable neurostimulation devices have the potential to ameliorate a number of debilitating conditions in which neural pathways play a role. Combined, these applications are expected to bring in device revenues of nearly $1.4 billion in the US alone in 2010, and that number is forecast to increase by double-digits going forward, reaching over $2.6 billion by 2014, according to Medtech Insight's recently published report, "US Markets for Neurostimulation Products."